CRL Annual Non Current Assets
$6.59 B
+$422.60 M+6.86%
30 December 2023
Summary:
As of January 21, 2025, CRL annual long term assets is $6.59 billion, with the most recent change of +$422.60 million (+6.86%) on December 30, 2023. During the last 3 years, it has risen by +$2.30 billion (+53.54%). CRL annual non current assets is now at all-time high.CRL Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly Non Current Assets
$6.51 B
+$60.11 M+0.93%
28 September 2024
Summary:
As of January 21, 2025, CRL quarterly long term assets is $6.51 billion, with the most recent change of +$60.11 million (+0.93%) on September 28, 2024. Over the past year, it has dropped by -$77.22 million (-1.17%). CRL quarterly non current assets is now -1.17% below its all-time high of $6.59 billion, reached on December 30, 2023.CRL Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.9% | -1.2% |
| 3 y3 years | +53.5% | -1.2% |
| 5 y5 years | +122.7% | -1.2% |
CRL Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.5% | -1.2% | +13.4% |
| 5 y | 5-year | at high | +79.4% | -1.2% | +77.3% |
| alltime | all time | at high | +4706.1% | -1.2% | +2145.9% |
Charles River Laboratories International Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.51 B(+0.9%) |
| June 2024 | - | $6.45 B(-0.5%) |
| Mar 2024 | - | $6.48 B(-1.5%) |
| Dec 2023 | $1.61 B(+11.8%) | $6.59 B(+6.9%) |
| Sept 2023 | - | $6.16 B(-1.7%) |
| June 2023 | - | $6.27 B(+0.3%) |
| Mar 2023 | - | $6.25 B(+1.4%) |
| Dec 2022 | $1.44 B(+12.9%) | $6.16 B(+3.3%) |
| Sept 2022 | - | $5.97 B(-2.8%) |
| June 2022 | - | $6.14 B(+6.9%) |
| Mar 2022 | - | $5.74 B(-0.1%) |
| Dec 2021 | $1.27 B(+6.1%) | $5.75 B(+1.2%) |
| Sept 2021 | - | $5.68 B(+4.2%) |
| June 2021 | - | $5.45 B(+24.3%) |
| Mar 2021 | - | $4.39 B(+2.2%) |
| Dec 2020 | $1.20 B(+17.6%) | $4.29 B(+5.3%) |
| Sept 2020 | - | $4.07 B(+1.7%) |
| June 2020 | - | $4.01 B(+0.3%) |
| Mar 2020 | - | $3.99 B(+8.8%) |
| Dec 2019 | $1.02 B(+13.8%) | $3.67 B(+1.7%) |
| Sept 2019 | - | $3.61 B(-0.1%) |
| June 2019 | - | $3.62 B(+18.1%) |
| Mar 2019 | - | $3.06 B(+3.5%) |
| Dec 2018 | $897.84 M(+8.6%) | $2.96 B(-0.0%) |
| Sept 2018 | - | $2.96 B(-0.6%) |
| June 2018 | - | $2.98 B(+37.9%) |
| Mar 2018 | - | $2.16 B(+2.6%) |
| Dec 2017 | $826.63 M(+25.9%) | $2.10 B(+0.9%) |
| Sept 2017 | - | $2.08 B(+2.4%) |
| June 2017 | - | $2.04 B(+1.9%) |
| Mar 2017 | - | $2.00 B(-2.8%) |
| Dec 2016 | $656.83 M(+17.5%) | $2.05 B(+1.0%) |
| Sept 2016 | - | $2.04 B(-1.3%) |
| June 2016 | - | $2.06 B(+40.6%) |
| Mar 2016 | - | $1.47 B(-2.8%) |
| Dec 2015 | $559.23 M(-3.5%) | $1.51 B(+3.8%) |
| Sept 2015 | - | $1.45 B(+15.8%) |
| June 2015 | - | $1.26 B(+1.9%) |
| Mar 2015 | - | $1.23 B(-4.5%) |
| Dec 2014 | $579.25 M(+4.8%) | $1.29 B(+4.4%) |
| Sept 2014 | - | $1.24 B(-2.7%) |
| June 2014 | - | $1.27 B(+19.8%) |
| Mar 2014 | - | $1.06 B(-1.8%) |
| Dec 2013 | $552.55 M(+13.9%) | $1.08 B(-1.4%) |
| Sept 2013 | - | $1.10 B(-0.5%) |
| June 2013 | - | $1.10 B(-0.8%) |
| Mar 2013 | - | $1.11 B(+0.9%) |
| Dec 2012 | $485.25 M | $1.10 B(-0.8%) |
| Sept 2012 | - | $1.11 B(+1.4%) |
| June 2012 | - | $1.09 B(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $1.12 B(-1.3%) |
| Dec 2011 | $425.84 M(-23.0%) | $1.13 B(+0.3%) |
| Sept 2011 | - | $1.13 B(-2.4%) |
| June 2011 | - | $1.16 B(-2.3%) |
| Mar 2011 | - | $1.18 B(+0.3%) |
| Dec 2010 | $552.89 M(-7.2%) | $1.18 B(-24.0%) |
| Sept 2010 | - | $1.55 B(+0.3%) |
| June 2010 | - | $1.55 B(-1.6%) |
| Mar 2010 | - | $1.57 B(-2.2%) |
| Dec 2009 | $595.60 M(-3.6%) | $1.61 B(-1.0%) |
| Sept 2009 | - | $1.63 B(+2.6%) |
| June 2009 | - | $1.58 B(+5.2%) |
| Mar 2009 | - | $1.51 B(-2.3%) |
| Dec 2008 | $618.14 M(+1.7%) | $1.54 B(-32.3%) |
| Sept 2008 | - | $2.28 B(+2.9%) |
| June 2008 | - | $2.21 B(+0.7%) |
| Mar 2008 | - | $2.20 B(+0.0%) |
| Dec 2007 | $607.86 M(+21.3%) | $2.20 B(+0.8%) |
| Sept 2007 | - | $2.18 B(+2.1%) |
| June 2007 | - | $2.14 B(+2.4%) |
| Mar 2007 | - | $2.09 B(+1.4%) |
| Dec 2006 | $501.09 M(+19.5%) | $2.06 B(+5.8%) |
| Sept 2006 | - | $1.94 B(-7.0%) |
| June 2006 | - | $2.09 B(+4.7%) |
| Mar 2006 | - | $2.00 B(-5.7%) |
| Dec 2005 | $419.32 M(-17.8%) | $2.12 B(+1.4%) |
| Sept 2005 | - | $2.09 B(+1.1%) |
| June 2005 | - | $2.07 B(-1.7%) |
| Mar 2005 | - | $2.10 B(-0.6%) |
| Dec 2004 | $510.31 M(+37.6%) | $2.12 B(+379.2%) |
| Sept 2004 | - | $441.69 M(+0.9%) |
| June 2004 | - | $437.77 M(-0.4%) |
| Mar 2004 | - | $439.46 M(+2.5%) |
| Dec 2003 | $370.89 M(+33.4%) | $428.67 M(+2.3%) |
| Sept 2003 | - | $419.06 M(-0.7%) |
| June 2003 | - | $422.19 M(+0.5%) |
| Mar 2003 | - | $419.95 M(-0.8%) |
| Dec 2002 | $278.09 M(+32.3%) | $423.25 M(+10.7%) |
| Sept 2002 | - | $382.39 M(-2.0%) |
| June 2002 | - | $390.17 M(+5.4%) |
| Mar 2002 | - | $370.06 M(+2.4%) |
| Dec 2001 | $210.15 M(+75.5%) | $361.21 M(-0.1%) |
| Sept 2001 | - | $361.49 M(+1.8%) |
| June 2001 | - | $355.14 M(-1.4%) |
| Mar 2001 | - | $360.18 M(+22.6%) |
| Dec 2000 | $119.74 M(+32.9%) | $293.81 M(-0.4%) |
| Sept 2000 | - | $294.85 M(+1.5%) |
| June 2000 | - | $290.56 M(+0.3%) |
| Mar 2000 | - | $289.83 M |
| Dec 1999 | $90.07 M(-7.3%) | - |
| Dec 1998 | $97.21 M | - |
FAQ
- What is Charles River Laboratories International annual long term assets?
- What is the all time high annual non current assets for Charles River Laboratories International?
- What is Charles River Laboratories International annual non current assets year-on-year change?
- What is Charles River Laboratories International quarterly long term assets?
- What is the all time high quarterly non current assets for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly non current assets year-on-year change?
What is Charles River Laboratories International annual long term assets?
The current annual non current assets of CRL is $6.59 B
What is the all time high annual non current assets for Charles River Laboratories International?
Charles River Laboratories International all-time high annual long term assets is $6.59 B
What is Charles River Laboratories International annual non current assets year-on-year change?
Over the past year, CRL annual long term assets has changed by +$422.60 M (+6.86%)
What is Charles River Laboratories International quarterly long term assets?
The current quarterly non current assets of CRL is $6.51 B
What is the all time high quarterly non current assets for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly long term assets is $6.59 B
What is Charles River Laboratories International quarterly non current assets year-on-year change?
Over the past year, CRL quarterly long term assets has changed by -$77.22 M (-1.17%)